Revolution Medicines, Inc.RVMDNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+57.0%
5Y CAGR+49.2%
Year-over-Year Change
Research and development spending
3Y CAGR
+57.0%/yr
vs +49.2%/yr prior
5Y CAGR
+49.2%/yr
Recent acceleration
Acceleration
+7.8pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
7.4x
Strong expansion
Streak
8 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $978.68M | +65.3% |
| 2024 | $592.23M | +40.0% |
| 2023 | $423.14M | +67.2% |
| 2022 | $253.07M | +35.4% |
| 2021 | $186.95M | +41.4% |
| 2020 | $132.25M | +44.1% |
| 2019 | $91.75M | +79.6% |
| 2018 | $51.08M | +92.1% |
| 2017 | $26.59M | - |